Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Maxidex (dexamethasone ophthalmic suspension), 0.1%, Alcon, NDA 13-422/S-035 CEFEPIME HYDROCHLORIDE (ARGININE FORMULATION) Injection 1GM BASE/VIAL MAXIPIME BRISTOL MYERS SQUIBB 050679 CEFEPIME HYDROCHLORIDE (ARGININE FORMULATION) Injection 2GM BASE/VIAL MAXIPIME BRISTOL MYERS SQUIBB 050679 CEFEPIME HYDROCHLORIDE (ARGININE FORMULATION) Injection 500MG BASE/VIAL MAXIPIME BRISTOL MYERS SQUIBB | MAXIPIME (cefepime hydrochloride) Powder for Injection, Bristol-Myers Squibb, Labeling Revision | Cefepime Hydochloride Injection, ACS Dobfar, Approval | Cefepime Injection, Baxter Healthcare Corp., Approval | Maxipime (cefepime hydrochloride) Injection, Bristol-Myers Squibb Co., Labeling Revision | Cefepime and Dextrose Injection, B. Braun Medical, Inc., Approval | Cefepime in Plastic Container (cefepime hydrochloride) Injection, Baxter Healthcare Corp., Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com